Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.46 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL276400 | 0.97 | — | — | |
| SCHEMBL11761433 | 0.94 | CACNA2D1 (0.46) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL27936231 | 0.94 | CACNA2D1 (0.46) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL27936230 | 0.94 | CACNA2D1 (0.46) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL8055157 | 0.89 | TDP1 (0.42) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL14359807 | 0.88 | CACNA2D1 (0.43) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL9723706 | 0.88 | CACNA2D1 (0.48) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL18532731 | 0.87 | CACNA2D1 (0.43) | CACNA2D1CACNB3CACNA1CPGRADRA1A | |
| SCHEMBL1813403 | 0.86 | — | — | |
| SCHEMBL7054844 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110790906-A | Method for synthesizing high molecular weight aliphatic polyester without catalyst and product thereof | 浙江大学 | 2020-02-14 | — | — | CN | claimed |
| CN-105246841-B | Inhibition of methane production during anaerobic reductive dechlorination | 创新环境技术公司 | 2018-06-26 | — | — | CN | claimed |
| EP-4705546-A1 | PRODUCING A STABLE ACTIVATED NICKEL OXIDE HYDROXIDE FOAM ELECTRODE | Evonik Operations GmbH (DE) | 2026-03-11 | — | — | EP | disclosed |
| WO-2025100494-A1 | BIODEGRADABLE POLYESTER RESIN, BIODEGRADABLE POLYESTER RESIN COMPOSITION, AND MOLDED BODIES THEREOF | 株式会社クラレ | 2025-05-15 | — | — | WO | disclosed |
| WO-2024227775-A1 | PRODUCING A STABLE ACTIVATED NICKEL OXIDE HYDROXIDE FOAM ELECTRODE | EVONIK OPERATIONS GMBH (DE) | 2024-11-07 | — | — | WO | disclosed |
| EP-4459010-A1 | PREPARATION OF STABLE ACTIVATED NICKEL OXYHYDROXIDE FOAM ELECTRODE | Evonik Operations GmbH (DE) | 2024-11-06 | — | — | EP | disclosed |
| WO-2022188825-A1 | XYLYLENE DIISOCYNATE COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | 万华化学集团股份有限公司 | 2022-09-15 | — | — | WO | disclosed |
| CN-113372691-B | Resin composition, reinforcing liquid, reinforcing layer, and optical protective film | 宁波长阳科技股份有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-113179643-A | Catalyst components for the polymerization of olefins | 巴塞尔聚烯烃意大利有限公司 | 2021-07-27 | — | — | CN | disclosed |
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2018-04-05 | — | — | US | disclosed |
| US-9783554-B2 | Lanthanide ion complexes and imaging method | THE UNIVERSITY OF AKRON (US) | 2017-10-10 | — | — | US | disclosed |
| US-5219700-A | Excellent development latitude, light safety, visible-on-exposure characteristic and printing resistance | MITSUBISHI KASEI CORPORATION (JP) | 1993-06-15 | — | — | US | disclosed |
| US-5182183-A | Chemical resistance; printing durability | MITSUBISHI KASEI CORPORATION (JP) | 1993-01-26 | — | — | US | disclosed |
| EP-0362778-A2 | Photosensitive composition | Mitsubishi Chemical Corporation (JP) | 1990-04-11 | — | — | EP | disclosed |
| EP-0287212-A1 | Positive photosensitive planographic printing plate | Mitsubishi Chemical Corporation (JP) | 1988-10-19 | — | — | EP | disclosed |
| US-4462934-A | BACTERICIDES FROM PENICILLINS AND PENICILLINASE INHIBITORS | PFIZER INC. (US) | 1984-07-31 | — | — | US | disclosed |
| US-4457924-A | PENICILLINS, OXAPENICILLINS, BETA-LACTAMASE INHIBITORS | PFIZER, INC. (US) | 1984-07-03 | — | — | US | disclosed |
| EP-0003274-B1 | O-SUBSTITUTED (+)-CYANIDAN-3-OL DERIVATIVES, METHOD FOR THEIR PREPARATION, AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR PREPARATION | Zyma SA (CH) | 1984-02-29 | — | — | EP | disclosed |
| EP-0003274-A1 | o-Substituted (+)-cyanidan-3-ol derivatives, method for their preparation, as well as pharmaceutical compositions containing these compounds and their preparation | Zyma SA (CH) | 1979-08-08 | — | — | EP | disclosed |
| US-4120858-A | HYPOTENSIVE, ARTERIOSCLEROSIS AGENTS | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | CACNA2D1 4639/4885CACNB3 3755/4885CACNA1C 4237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.